An Important NEWS UPDATE (SUMMER 2022) from the RITHIM Team.Please click on the link below to read the full update now:
Research Manitoba Announces New Initiative in Collaboration with the pharmaceutical and health tech industry for patients living with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia in Manitoba
For Immediate Release
June 15, 2022 – Winnipeg, Manitoba
Research Manitoba, in collaboration with Novartis Canada and MindSet, is proud to announce an exciting new research project which will focus on the evaluation of LDL cholesterol treatment, cardiovascular events, and healthcare costs among individuals with atherosclerotic cardiovascular disease (ASCVD) and Familial Hypercholesterolemia (FH) in Manitoba.
Currently, ASCVD is a leading cause of morbidity and mortality worldwide and FH is estimated at about 1/300 persons worldwide. ASCVD is a hardening and narrowing of the arteries caused by cholesterol plaques lining the artery over time and can put blood flow at risk as arteries become blocked. FH is a hereditary disorder and causes LDL (bad) cholesterol levels to be very high. The condition begins at birth and can cause heart attacks at an early age. Canadian Journal of Cardiology, Volume 34 (2018) 1553-1563
Research Manitoba and Novartis Canada are providing the financial investment over two years and MindSet (Manitoba’s INtegrated Data Set) and Novartis are collaborating to operationalize the research project. The project objective is to identify the most effective strategy for lowering LDL-C and costs.
“The health of Manitobans and strengthening healthcare in Manitoba is our government’s top priority,” said Health Minister Audrey Gordon. “Our government continues to search for and support innovative ways to address significant challenges to the health-care system exemplified by this research collaboration with Novartis Canada, MindSet and Research Manitoba. We look forward to the affect research such as this will have on the health-care system in Manitoba and for all Canadians.”
“We are pleased to collaborate with Novartis Canada and MindSet on this innovative research project that will use integrated real-world data to evaluate the impact of a therapeutic treatment to improve patient health outcomes,” said Karen Dunlop, CEO of Research Manitoba.
The research project team will conduct a retrospective study using health administrative databases to report the point prevalence of ASCVD in Manitoba and to describe this population in terms of demographic, clinical characteristics, treatment received, and health care resource utilization. Additionally, data from the study will support the creation of a HEOR model to estimate the impact in Manitoba of using inclisiran in the management of hypercholesterolemia in an ASCVD population.
“Public Private Partnerships can be a powerful way to solve large-scale healthcare challenges. With this data-driven project, Novartis is committing to partnering with Manitoba on the pressing healthcare issue of ASCVD in ways that both meet the province’s goals, needs, and priorities and accelerates the identification, treatment, and support of patients,” said Andrea Marazzi, Country President, Novartis Pharmaceuticals Canada Inc. “I commend Research Manitoba and MindSet for their innovative approach to addressing the immense burden this disease has on our healthcare system health and on the health and well-being of Canadians.”
This initiative marks an innovative public-private collaboration that will bridge the gaps in real-world evidence for the treatment of ASCVD and FH. The goal is for the findings to support the lowering of LDL-C and improving patient health outcomes and healthcare costs for Canadians.
For more information please contact:
Tammy Hildebrand, Manager, Communications
Download the PDF version of the Full News Release: NEWS RELEASE- RMB_Novartis_ MindSet_ 15_06_2022_ FINALV
Important Information for Researchers
1) *New* RITHIM Website Updates
As of April 27, 2022, all information and forms related to provincial health research privacy review have been moved to the RITHIM website under the Privacy (PHRPC) menu. Researchers are strongly encouraged to bookmark the new site and check back often for updates.
2) *New* Updated Provincial Health Research Privacy Committee (PHRPC) Application Form
In response to feedback from the committee and the research community, the PHRPC Application Form has been updated. The new form, dated April 2022, can be found here.
Please use the new form going forward. Old versions of the form will no longer be accepted as of June 7, 2022. The updated form incorporates a few new key questions which will provide clarity to both researchers and the committee on (i) whether their project requires PHRPC review and (ii) data security considerations.
3) *New* PHRPC Policy Update – Data Requirements
PHRPC can now approve the use of data for the length of a project, up to a maximum of 5 years, at which time the project must be reviewed by PHRPC. Amendments will no longer be required for adding new years of data if the data requested and the scope of the data to be used does not change.
4) *Reminder* - HIPC Applications That Have Received Conditional Approval
For all applications that received conditional approval from the HIPC committee prior to January 1, 2022, applicants have one year from the date of the conditional approval to resubmit to the HIPC for review. If the requested information is not submitted within this time period, a new application will need to be submitted to the PHRPC. Please email the pending documents and responses to conditional approval letter to HIPC@gov.mb.ca for review and full approval.
5) *Reminder* - Amendments to Research Projects Approved by HIPC
Any proposed changes to a research project that was approved by the HIPC must be reported to the PHRPC for review and approval in advance of its implementation. For more information, and to find the amendment form, please visit the RITHIM website.
For inquiries or for more information, please contact: PHRPC@researchmb.ca
To download the PDF version please click on link: May 16,2022_Important Information for Researchers from RITHIM
Research Manitoba, Boehringer Ingelheim (Canada) Ltd. and First Nations Health and Social Secretariat of Manitoba Announce Chronic Kidney Disease Screening Program in the Manitoba Adult First Nations Population
For Immediate Release
April 6, 2022 – Winnipeg, Manitoba
Research Manitoba, Boehringer Ingelheim (Canada) Ltd., and the First Nations Health and Social Secretariat of Manitoba are proud to announce an exciting project ‘Optimizing First Nations Chronic Kidney Disease and Diabetes Care’ which will focus on the early identification and management of chronic kidney disease (CKD) and diabetes via Virtual Kidney Check and Follow-up involving a unique collaboration of stakeholders. The project is being funded through the Boehringer Ingelheim-Research Manitoba (BI-RM) Partnership Fund. This fund supports community-based research and innovation projects focused on improving diabetes-related health outcomes within urban, rural and remote Indigenous communities in Manitoba.
Manitoba has the highest incidence and prevalence of kidney failure in Canada that is driven by a disproportionate burden of diabetes and CKD in First Nations communities. First Nations peoples are at an increased risk of developing CKD and face many barriers to accessing health care. Diagnoses are often delayed and the opportunities to modify risk and disease progression with lifestyle interventions and medications are often missed. A new approach is urgently needed to improve the lives of First Nations peoples across Manitoba with or at-risk of developing chronic kidney disease.
Through the Boehringer Ingelheim-Research Manitoba (BI-RM) Partnership Fund, Drs. David Collister & Paul Komenda (University of Manitoba), along with the First Nations Health Social Secretariat of Manitoba (FNHSSM) will create a public health screening program using an integrated health dataset, telenephrology for screening, and risk stratification and management of CKD in First Nations adults across Manitoba. This project is one of three demonstration trials within MindSet – Manitoba’s Integrated Data Set to demonstrate the use and value of provincially integrated health data to answer critical questions about quality, outcomes, cost, and equity in the health system. MindSet is a partnership between the University of Manitoba and Manitoba Health and Seniors Care and will contribute to the province’s efforts to build a provincial health data platform. A key deliverable of this research is the creation of a public health screening program for CKD in all Indigenous adults in Manitoba. A registry and data platform of Indigenous adults at risk of CKD will be created by FNHSSM to continue monitoring kidney health of Indigenous adults that will be shared with government and key stakeholders to create awareness of the health status and resources needed in the communities.
Based on patient-centricity and Indigenous-led care, the Boehringer Ingelheim-Research Manitoba (BI-RM) Partnership Fund aligns Boehringer Ingelheim Canada’s PATHWAYS Framework to include the perspectives of Indigenous leadership to ensure research strategies are directly informed through Indigenous knowledge and community participation. All aspects of community engagement will be done in collaboration with the FNHSSM and Manitoba Patient Partners with lived experience of chronic kidney disease.
“The high prevalence of chronic kidney disease and diabetes in Manitoba is a critical issue facing our province’s healthcare system. Finding innovative and effective solutions to address this requires a unique partnership such as this. We are proud to partner with Boehringer Ingelheim (Canada) on the Boehringer Ingelheim-Research Manitoba (BI-RM) Partnership Fund supporting this important research. This strategic partnership with Boehringer Ingelheim Canada and FNHSSM provides Manitoba with an opportunity to help improve chronic kidney disease and diabetes health outcomes within Indigenous communities in Manitoba and advance more equitable access to care among Manitoba’s Indigenous communities,” said Karen Dunlop, CEO of Research Manitoba.
“Creating innovative healthcare solutions for all Canadians is part of our purpose as a company in Canada. We believe by partnering with Indigenous communities, companies and organizations we can help to address healthcare gaps for all Canadians. Addressing system gaps by partnering with researchers and stakeholders will drive patient-centric healthcare with respectful and culturally appropriate education, resources, and support to Indigenous Peoples in a community-driven way,” said Andrea Sambati, President and CEO of Boehringer Ingelheim (Canada) Ltd.
“This is an opportunity to create a First Nations co-led diabetes surveillance strategy that adheres to the First Nations principles of OCAP (ownership, control, access and possession) and asserts First Nations data sovereignty through the signing of information sharing agreements that outline the terms of collection and use of First Nations data that supports the urgent need to address the high prevalence of diabetes amongst Manitoba First Nations and complications resulting from diabetes through screening and access to primary care specialists before complications negatively impact the wellbeing of First Nations who may be at risk of developing diabetes. First Nations children within Manitoba are “25 times more likely to be diagnosed with diabetes than other Manitobans”, we need to begin screening at earlier stage, this partnership will provide the evidence needed to intervene at an earlier stage based before complications begin,” said Leona Star, Director of Research with the FNHSSM.
“Indigenous peoples living in rural and remote parts of the province often have barriers in accessing diagnostic and treatment options for conditions such as kidney disease and diabetes. Innovative projects like this, that include Indigenous leadership in addressing health issues and in the development of solutions will help to empower and optimize care for Indigenous Manitobans,” said Alan Lagimodiere, Minister for Indigenous Reconciliation and Northern Relations.
“This project will determine the best way to operationalize population-based screening for chronic kidney disease and diabetes in First Nations adults living in Manitoba. The goal is to identify kidney disease early and initiate disease modifying therapy including blood pressure control and medications that significantly reduce the risk of heart disease and kidney failure. We want to create a population-based screening program, similar to cancer screening programs, but expanded to all Indigenous persons in Manitoba to prevent the complications of diabetes and kidney disease that are negatively impacting health and quality of life,” said Dr. David Collister, nephrologist and assistant professor at the University of Manitoba.
This initiative marks a leading public-private collaboration in Indigenous healthcare in Canada and, if proven successful, will determine the most effective way to complete population-based screening for chronic kidney disease in First Nations adults in Manitoba.
Tammy Hildebrand, Manager, Communications
Download the PDF version of the Full News Release: RM-BI-FNHSSM News Release_ENG and FRENCH_ FINALV
Watch our Partnership Video: https://youtu.be/Av2BrT_Ic1A
Today Research Manitoba announces the new provincial initiative Research Improvements Through Harmonization in Manitoba (RITHIM)
For Immediate Release
RITHIM: A new way forward for health research in Manitoba
(Winnipeg, Manitoba) Monday, April 4, 2022 –Health research in Manitoba has a high value to our society. It can provide important information about disease trends, outcomes of treatment, and public health interventions, as well as give Manitobans, access to leading-edge clinical trials. Conducting health research on humans requires a rigorous review of human ethics and privacy. Navigating these necessary reviews has been cumbersome and lengthy, involving many organizations with as many processes and timelines. Research Manitoba is leading the way to a better system with the new provincial initiative Research Improvements Through Harmonization in Manitoba (RITHIM). RITHIM will streamline and harmonize the review processes related to health research in Manitoba. This innovative program will create a more efficient and effective pathway for researchers including all the necessary checks and balances while cutting down the lengthy time for approval that currently exists in the province. RITHIM and its innovative platform will make it faster and easier to conduct health research, making Manitoba one of the most attractive provinces in Canada to conduct health research.
“The advantages that this innovative program creates will have on the health-care system are numerous. Increasing the effectiveness and efficiency in health research methods while ensuring rigorous review to protect Manitobans will help to position our province as an extremely attractive health research center.”
- Audrey Gordon, Minister of Health
“Navigating the complex environment related to human research has been a barrier to delivering cutting edge care to Manitobans at the developmental stage. RITHIM addresses this problem head on and is a much welcome solution by the research community who are committed to advancing patient care in Manitoba.”
- Dr. Peter Nickerson, Vice Dean Research, Rady Faculty of Health Sciences, University of Manitoba, Medical Director Transplant Manitoba
RITHIM received support from the Ministers of Health and the Economy in 2015 and again in 2017 when Research Manitoba was asked to lead the implementation of a series of recommendations to transform the system for health research approvals in Manitoba. RITHIM is the most ambitious project undertaken by Research Manitoba. It was designed by the research community over several years with many stakeholders including the Manitoba government, Shared Health, Regional Health Authorities, Healthcare and Research Institutions, Post-Secondary Institutions, Researchers, and Industry.
“Our province has a lot of innovative healthcare researchers with the skills and knowledge to help their fellow Manitobans. Today’s announcement will be very beneficial in helping to attract additional investments to the province. By having a better streamlined process, it will shorten the timelines for the reviews and approvals needed to conduct health research, including clinical trials. This move will help research to be more in line with the modern speed of business.”
- Cliff Cullen, Minister of Economic Development, Investment and Trade
RITHIM will streamline the applications through the electronic Provincial Research Administration System (PRAS) and harmonized review processes, making it easier and faster to conduct health research in Manitoba while maintaining the highest levels of ethics and privacy protection.
“RITHIM will reduce the administrative burden for researchers, in turn, attracting talent and cutting-edge clinical trials to Manitoba.”
-Karen Dunlop, Chief Executive Officer, Research Manitoba
“The University of Manitoba has supported RITHIM since its inception. The harmonization and streamlining it facilitates will benefit Manitoba’s researchers and will help attract clinical trial investments in Manitoba. The University of Manitoba is pleased to continue to support RITHIM through a variety of in kind supports.”
-Dr. Digvir S. Jayas, Vice-President (Research and International), University of Manitoba
RITHIM launched its first phase of the program on January 1, 2022, when amendments were made to The Personal Health Information Act (PHIA). These amendments enabled the formal implementation of the RITHIM program, including the establishment of the Provincial Health Research Privacy Committee (PHRPC) as the only committee authorized to review and approve requests to access personal health information for research purposes. The Committee for Harmonized Health Impact, Privacy, and Ethics Review (CHIPER) will conduct ethics reviews for all initiatives going forward.
The full RITHIM program, including phase two of the execution of PRAS, will be implemented later in 2022.
Tammy Hildebrand, Manager, Communications
Download the PDF version of the RITHIM News Release 2022-04-04_RITHIM News Release_FINAL
Innovative Solutions and Products Created in Manitoba: $200,000 in Research Funding for Two New Innovation Proof-of-Concept Grants
October 21, 2021 – Winnipeg, Manitoba. Today Research Manitoba announces $200,922 in research funding to support two new Innovation Proof-of-Concept Grants. Research Manitoba’s investment leverages $101,000 and supports Manitoba-based projects in the areas of Bioscience and Advanced Manufacturing.
This research funding will foster research innovation, economic development, and the commercialization of products, through the movement of innovations from ideas to market usability.
“Our government is pleased to partner with Research Manitoba, in order to create jobs and support the development of local businesses,” said Minister of Economic Development and Jobs Jon Reyes. “By making investments in important research, we are helping Manitobans create innovative solutions that will help people across this province and beyond.”
“Congratulations to our recent Innovation Proof-of-Concept recipients,” said Karen Dunlop CEO, Research Manitoba. “We are proud to promote Manitoba’s economic growth by supporting local academic and industry research and development.”
These innovative projects will enhance and strengthen technology or product maturity towards market usability, encourage research and development that will accelerate technology transfer and commercialization of innovative products, processes, and services, and support talent development and build capacity for translational research in Manitoba.
Recipient for Stream 1: Manitoba-Based Consortium
Academic Institution: Red River College Polytechnic
Industry Partner: Carbon Lock Technologies Inc.
Project Title: The Production of Biocarbon from Organic Waste and its utilization in Sustainable Landfill Management, Wastewater Treatment, Municipal Infrastructure, Carbon Sequestration and New Materials and Manufactured Goods
Research Manitoba: $101,000 Leveraged funds: $101,000
Recipient for Stream 2: Manitoba Post-Secondary Researchers Jacob Burgess, Department of Physics and Astronomy, Faculty of Science, University of Manitoba Project Title: Digital Fabrication of Low-Cost Sub-Millimeter Wave Optics
Research Manitoba: $99,922
From Ideas to Market – Advancing Research and Innovation in Manitoba - $2.1M in Research Funding for Local Researchers and Companies
August 26, 2021 – Winnipeg, Manitoba. Research Manitoba is proud to announce $2,094,900 in research funding to support seventeen Innovation Proof-of-Concept Grants. Research Manitoba’s investment leverages $2.13M and supports Manitoba-based projects in Biosciences, ICT, Advanced Manufacturing, and Infrastructure and Transportation Industries and Technologies.
These funds will foster research innovation and development in the Technology Readiness Levels 3-7 range, economic development and commercialization of products, and the movement of innovations from ideas to market usability.
“The Innovation Proof-of-Concept Grant provides funding for commercialization research that supports an inspiring level of collaboration, advances discovery, and propels local companies and industries toward market usability,” said Hon. Minister Jon Reyes, Minister of Economic Development and Jobs. This type of growth and development is vital to our province’s future as this type of research creates jobs and strengthens Manitoba’s research enterprise and innovation ecosystem with solutions that will help people across this province and beyond.”
“This new program brings together government, researchers, local companies and academic institutions, which fosters community development and provides local companies and industry the opportunity to enhance their skills, products, and technologies,” said Karen Dunlop CEO, Research Manitoba. “I congratulate each stakeholder group on their efforts and commitment to expand our province’s innovative capacities. Our team looks forward to seeing these projects unfold and the many outcomes that will follow.”
$1.9M Research Infrastructure Funding to Support Manitoba’s Research Leaders and Enhance Technology and Business Innovation
2021 Research Competition Results - Trainee Awards and New Investigator Operating Grants
July 28, 2021 – Today Research Manitoba and partners announced $1.37M in research funding and the recipients of the 2021 Grants and Awards competition. Funding will support 32 Master’s Studentships, seven PhD Studentships, two Postdoctoral Fellowships, and eight New Investigator Operating Grants in Manitoba in health, social sciences and humanities, and natural sciences and engineering. Research Manitoba invested $993,905 and our partners provided an additional $373,100 for the Trainee Awards.
Our partners for the 2021 Awards Competition:
- CancerCare Manitoba Foundation
- Children’s Hospital Research Institute of Manitoba (CHRIM)
- George & Fay Yee Centre for Healthcare Innovation (CHI)
- Health Sciences Centre Foundation
- Lung Association, Manitoba
- University of Manitoba, Regenerative Medicine Program, WM Ross Scholarship
The recipients of the 2021 Grants and Awards Competition are highly qualified Trainees and New Investigators in Manitoba. These awards enable recipients to prepare and train for their careers as independent researchers in industry or within the provincial research enterprise, establish independent research programs, and achieve the skills necessary to compete on a national level.
Advancing Hip and Knee Joint Replacement Research in Manitoba
Stepping Farther Together.
Today Research Manitoba and the Concordia Foundation announced a partnership and $500,000 in research funding to support Dr. Thomas Turgeon as the Arthroplasty Research Chair at Concordia’s Hip and Knee Replacement Institute!
This five-year Research Chair position will allow Dr. Turgeon and researchers at Concordia's Hip and Knee Institute to take a step forward in delivering world-class treatment, improving operating room efficiencies, and accelerating innovative approaches to healing the growing number of Manitobans living with hip and knee pain and disability.
“We are very excited to be partnering with the Concordia Foundation on this important project. Advancements in care require research in many areas. This project will support our shared commitment to excellence by enabling Dr. Turgeon and his team to accelerate their research to help Manitobans get back on their feet and improve their lives.” Ms. Karen Dunlop, CEO, Research Manitoba.
Research Manitoba and NSERC Launch the Alliance-Accelerate, Commercialize, Transform (ACT) Program
(La version française suit)
Fostering Innovation and Commercialization through Research
Research Manitoba and NSERC Launch the Alliance-Accelerate, Commercialize, Transform (ACT) Program
(Winnipeg, Manitoba) May 18, 2021 – Research Manitoba and the Natural Sciences and Engineering Research Council of Canada (NSERC) are partnering to support industry-academic research and development collaborations to assist Manitoba-based small and medium enterprises’ (SMEs) innovations with the highest potential for provincial economic development and commercialization.
The NSERC Alliance-Research Manitoba Accelerate, Commercialize, Transform (ACT) Program provides funding for eight new projects in the priority areas of Bioscience, Information and Communications Technology, Advanced Manufacturing, and/or Infrastructure and Transportation Industries and Technologies. It will give Manitoba-based SMEs and university researchers in the natural sciences and engineering fields, the opportunity to leverage federal and provincial research funding to advance promising innovations toward commercialization.
This two-year grant offers industry-academic research teams the opportunity to match Manitoba-based SME funding. Research Manitoba will match the contributions at a 1:1 ratio, up to $25,000 per year for up to two years, and NSERC will match cash contributions from all recognized partners at a 2:1 ratio, from $20,000 to $1 million per year for up to five years.
The NSERC Alliance-Research Manitoba Accelerate, Commercialize, Transform (ACT) Program will begin accepting applications on May 18, 2021. For more details, please visit the Research Manitoba and NSERC websites.
Favoriser l’innovation et la commercialisation grâce à la recherche
Research Manitoba et le CRSNG annoncent la création des subventions Alliance-ACT (Accelerate, Commercialize, Transform)
Winnipeg (Manitoba), le 18 mai 2021 – Research Manitoba et le Conseil de recherches en sciences naturelles et en génie du Canada (CRSNG) travaillent en partenariat pour appuyer les collaborations universités-industrie en recherche et développement (R et D) visant à aider les petites et moyennes entreprises (PME) établies au Manitoba à mettre au point des innovations hautement susceptibles d’être commercialisées et de favoriser le développement économique de la province.
Les subventions Alliance (CRSNG)-ACT (Research Manitoba) seront accordées à huit nouveaux projets menés dans l’un des domaines prioritaires suivants : biosciences, technologies de l’information et des communications, fabrication de pointe, et technologies et industries des infrastructures et du transport. Cette possibilité de financement permettra aux PME établies au Manitoba et aux chercheurs universitaires en sciences naturelles et en génie d’obtenir des fonds fédéraux et provinciaux pour la recherche visant à perfectionner des innovations prometteuses en vue de leur commercialisation.
La subvention de deux ans offre à des équipes de recherche universités-industrie la possibilité d’obtenir un montant correspondant à la contribution de la PME établie au Manitoba. Research Manitoba accordera un montant égal à la contribution de la PME (ratio de 1:1), jusqu’à un maximum de 25 000 $ par an pendant au plus deux ans. Quant au CRSNG, il déterminera le montant de la subvention en fonction des contributions en espèces de tous les partenaires reconnus, selon un ratio de 2:1; sa subvention se situera entre 20 000 $ et un million de dollars par an, pendant un maximum de cinq ans.
Four Manitoba Companies Receive Funding for COVID-19 Research
May 3, 2021 - Research Manitoba is investing and leveraging more than a half-million dollars to support the provincial COVID-19 response by championing local industry-academic research partnerships.
Research Manitoba’s $361,442 investment will support four COVID-19 Innovation Proof-of-Concept grants, as well as leverage $165,000 from other sources to provide a total of $525,442 to support this vital work.
This support for four innovative Manitoba-based companies will create opportunities for employment and talent development, industrial research and technology collaborations to advance virtual lifestyle programming, COVID-19 testing, personal protective equipment (PPE) and infection prevention.
Chronic Disease Innovation Centre (CDIC)/Fusion Group/ Wellness Institute/University of Manitoba
Intrinsic Analytics Inc./St. Boniface Research Centre/University of Manitoba
Protective Textiles International (PTEX)/St. Boniface Research Centre/University of Manitoba
utR Biotech/University of Manitoba
NEW CONTEST GIVES MANITOBANS CHANCE TO NAME STATE-OF-THE-ART TELEPRESENCE ROBOTS
April 20, 2021
Winnipeg, MB – Victoria General Hospital Foundation, Research Manitoba and the College of Rehabilitation Sciences at the University of Manitoba’s Rady Faculty of Health Sciences announced a contest today to name 15 new telepresence robots. Participants can submit names through The Vic Foundation website at TheVicFoundation.ca for their chance to win a special prize package.
These telepresence robots are part of a new study by UM researchers which will assess whether these robots can effectively support informal caregivers of individuals living with dementia. This study was funded through an inaugural strategic partnership between The Vic Foundation and Research Manitoba.
The strategic partnership between The Vic Foundation and Research Manitoba is designed to promote innovation, support local research, and advance the economy.
“Our partnership with The Vic Foundation is very exciting for us and the many talented researchers working on this community-based project,” says Karen Dunlop, Chief Executive Officer of Research Manitoba. “Because it has the potential to advance bioscience innovation in our province and impact families, caregivers, and individuals living with dementia. This contest is a unique way for Manitobans to connect with and champion the research community.”
Manitobans have until May 14, 2021 to submit their names, and the winners will be announced on social media on May 21. 2021.
Read the Full Release
$5.4M Research Infrastructure Funding Supports Cutting-Edge Research in Manitoba
April 13, 2021 - Today, Research Manitoba announced a $5,396,813 research infrastructure funding investment for seven, state-of-the-art projects at the University of Manitoba and The University of Winnipeg. These projects are also supported through the Canada Foundation for Innovation (CFI) Innovation Fund and leverage $8.1M into our province.
Supporting these innovative projects will drive Manitoba’s researchers to the forefront of national and global research areas such as mother-infant health, quantum materials, and subatomic physics and will provide opportunities to manufacture medical imaging devices and create new technologies. The funding will aid the Canadian Longitudinal Study on Aging (CLSA) and promote reconciliation through acknowledgement as the National Centre for Truth and Reconciliation's (NCTR) implements a digital architecture, which enables innovative research meaningful to Indigenous communities.
“These projects allow Manitoba to continue to be innovative in a number of critical fields,” said Ralph Eichler, Minister of Economic Development and Jobs. “Our government will continue to support these research investments, which will benefit all Manitobans and provide economic growth through involvement of our local industries.”
“Providing opportunities for Manitoba’s researchers and innovators to partner here at home is essential for the future of our province, said Karen Dunlop, Chief Executive Officer at Research Manitoba. “I congratulate all of our Innovation Fund recipients on their success and know that their work will advance research in Manitoba and improve many aspects of our society.”
Research Manitoba Announces New CEO
February 9, 2021 – Research Manitoba, a provincial research funding agency, today announced Karen Dunlop as new Chief Executive Officer.
The Board of Directors would like to thank the Research Manitoba team for their efforts and Sean McKay, Interim CEO, for his direction and contributions in recent months; the momentum recently achieved has the organization well-positioned to forge ahead.
The Board welcomes Karen and the expertise and wealth of knowledge she brings to this role; she has served in a number of senior leadership capacities over the past 20 years and her capabilities include transforming organizations in the healthcare, professional regulation, insurance, and professional services sectors in Manitoba. Karen’s skills and certification in leadership, change management, governance, and executive coaching will serve as an excellent foundation as she guides the organization to advance research in Manitoba and to champion the province’s research community.
“Karen is a proven leader; her operational experience, breadth of knowledge, and keen ability to connect with stakeholders will allow Research Manitoba to focus on increasing Manitoba’s global competitiveness through strategic investment in world-class research,” said Andrea Legary, Research Manitoba Board Chair. “Together we will continue to build the Research Manitoba success story.”
Appointment of Ms. Andrea Legary as Board Chair
December 21, 2020 - Research Manitoba announces the appointment of Ms. Andrea Legary as the new Chair of the Board of Directors.
Ms. Legary, who joined Research Manitoba’s board in 2019, succeeds Ms. Tracey Maconachie, who served as Chair until her recent appointment to the position of Deputy Minister for the Department of Economic Development and Training.
We are also excited to share the premiere of our new video Building Our Future Through Investments in Research. An overview of Manitoba’s world-class research and innovation enterprise and the connection to our communities, our economy, and our future.
Research Manitoba and Boehringer Ingelheim Canada Partnership to Invest in Diabetes Care in Indigenous Populations in Manitoba
November 30, 2020 - Winnipeg Manitoba. Research Manitoba and Boehringer Ingelheim (Canada) Ltd. are excited to announce a new partnership, with the creation of the Boehringer Ingelheim-Research Manitoba (BI-RM) Partnership Fund. The fund will support community-based research and innovation projects focused on improving diabetes health outcomes within Indigenous communities in Manitoba.
Support from the BI-RM Partnership Fund will align with the province of Manitoba’s Shared Health Clinical and Preventative Services Plan, and Boehringer Ingelheim Canada’s PATHWAYS – Indigenous Health Collaborations, a partnership established with Bimaadzwin intended to empower Indigenous communities in improving health and wellness.
“We are very excited about entering into this collaboration with our renowned partner, Boehringer Ingelheim Canada, to provide support for Indigenous-led projects to improve health systems and patient care in their communities,” said Sean McKay, Interim CEO, Research Manitoba. “This is the second of what we anticipate to be many collaborations through Research Manitoba’s recently launched Strategic Partnerships Program that aims to leverage relationships and funding to significantly increase the amount of research carried out in Manitoba for the benefit of the community at large.”
Research Manitoba Announces Strategic Partnership and Funding for Health Research Innovation in Manitoba
September 24, 2020 – Winnipeg, Manitoba. Honourable Ralph Eichler, Minister of Economic Development and Training, launched Research Manitoba’s first Strategic Partnership with the Victoria General Hospital Foundation (VGHF). Today the partners announced $470,000 in research funding to support a health research competition to begin in the Fall of 2020 ($110,000) and a research study, which uses telepresence robots to remotely interact between persons with dementia (PWD) and their caregivers to extend stay at home care opportunities ($360,000).
“Our province is committed to ensuring that our research and innovation investments are aligned with industry need and health care priorities,” said Ralph Eichler, Minister of Economic Development and Training. “This partnership will lay the groundwork for meaningful health and economic outcomes, while improving the health and well-being of all Manitobans.”
This strategic partnership is a model for other partnerships, bringing together industry and research, supporting innovation in Manitoba. The Strategic Partnership Program engages with new sectors of industry, builds collaborations that create economic growth, provides employment opportunities, and supports local talent.
Research Manitoba Funds COVID-19 Rapid Response Grants and Clinical Trials in Manitoba
September 4, 2020 – Winnipeg, Manitoba. Today Research Manitoba announced $3.8M in research funding to support the recipients of the Manitoba COVID-19 Rapid Response Grant Competition and eight Manitoba clinical trials related to COVID-19 and applied health research. This funding has leveraged a further $5.6M from our partners to provide a total of $9.4M to support this essential work.
“Our government is committed to keeping Manitobans healthy and safe, especially as we navigate the current global pandemic. Manitoba is home to a highly-skilled, world-class research community who are on the front lines of the fight against COVID-19. This funding partnership with Research Manitoba will provide substantial financial support for cutting-edge research and clinical trials to address the effects of this virus.” - Hon. Cameron Friesen, Minister of Health, Seniors and Active Living.
“Earlier this year the Province of Manitoba provided Research Manitoba with an opportunity to support clinical trials and applied health research related to COVID-19” said Sean McKay, Interim CEO, Research Manitoba. “As a result, we immediately stimulated strong partnerships and provided funding opportunities for our world class Manitoba-based research teams to participate in the global response. It is heartening to see how our provincial government, researcher and stakeholder communities have so rapidly come together to support this crucial research.”
Supporting Local Talent and Research Excellence in Manitoba
August 28, 2020 – Today Research Manitoba and partners announced $1,182,361 in research funding to support 30 Master’s Studentships, two PhD Studentships, two Postdoctoral Fellowships, and seven New Investigator Operating Grants in Manitoba in health, social sciences and humanities, and natural sciences and engineering.
The recipients of the 2020 Grants and Awards Competition are highly qualified trainees and new investigators in health, natural sciences and engineering, and social sciences and humanities in Manitoba. The Grants and Awards prepare recipients for careers as independent researchers in industry or within Manitoba’s research enterprise and help to establish independent research programs and achieve the research productivity necessary to compete on a national level.
Research Manitoba Announces Appointment of Interim CEO
Wednesday, August 19, 2020 - Research Manitoba announces today the appointment of Mr. Sean McKay, as Interim Chief Executive Officer.
“Mr. McKay is an experienced professional who brings a broad range of skills acquired through his leadership positions in a variety of industry and research settings and will make an excellent addition to the team,” said Ms. Tracey Maconachie, Research Manitoba Board Chair. “All of us at Research Manitoba look forward to working with Sean as we continue to support the provincial research enterprise.”
“I am looking forward to applying my experience and network connections to support Research Manitoba during this transitional period and especially excited to be involved in the introduction of new programs advancing leading edge research in Manitoba and the implementation of the Research Improvements Through Harmonization In Manitoba (RITHIM) initiative.” Mr. Sean McKay, Interim CEO, Research Manitoba.
Manitoba Companies Receive Funding for COVID-19 Innovation Proof-of-Concept Grants
August 11, 2020 – Winnipeg, Manitoba
Today Research Manitoba is pleased to announce a $250,000 investment to support two COVID-19 Innovation Proof-of-Concept (IPoC) Grants to local companies Adva Diagnostics Inc. and Cubresa Inc. These grants will support innovative research projects from these Manitoba-based companies who have the expertise to help fight the COVID-19 pandemic.
Adva Diagnostic Inc., a venture of InnovoXL, received $150,000 for their project to develop new on the spot tests for COVID-19 and other infectious diseases, which can help us safely return to work and more normal lives. Adva will provide $33,750 in-kind toward their IPoC Grant with an additional $112,500 from Mitacs.
Cubresa Inc. received $100,000, which builds on their expertise in creating new imaging tools, making them safe to use with highly infectious diseases like SARS COV-2. This is a critical step to understanding and developing new treatments for the disease. Cubresa will provide $36,500 in-kind toward their IPoC Grant.
Manitoba’s First Indigenous Research Chair in Nursing
Mentoring the Next Generation of Nursing Leaders
June 25, 2020 – Winnipeg, Manitoba
Today Research Manitoba announced $258,500 in research funding to support Manitoba’s first Indigenous Research Chair in Nursing: Wanda Phillips-Beck, Seven Generations Scholar, RN, MSc, PhD(c) and the project titled ‘Mentoring Nurse Leaders and Researchers in Indigenous Health Grounded in Culturally and Equity Informed Approaches to Research and Education’.
Ms. Wanda Phillips-Beck is associated with the First Nations Health and Social Secretariat of Manitoba (FNHSSM) and the project is supported in partnership with the Canadian Institutes of Health Research (CIHR), and the Canadian Nurses Foundation (CNF). Together the investment totals $985,000:
- Research Manitoba: $258,500
- CIHR: $699,500
- CNF: $27,000
$5-MILLION FUND FOR RESEARCH PROJECTS RELATED TO COVID-19
April 8, 2020 - New Fund to Advance Strides Toward Vaccines and Treatments for Coronavirus
A new, $5-million COVID-19 research fund through Research Manitoba was announced today by Health, Seniors and Active Living Minister Cameron Friesen.
“This new fund will support a clinical trial to determine if a commonly used drug can safely be used as a treatment for COVID-19,” said Friesen. “The fund will also provide support for local researchers to develop solutions to health-care issues in response to the COVID-19 pandemic.”
In February, following a recommendation from Dr. Brent Roussin, chief provincial public health officer, the Canadian Institutes of Health Research, with numerous partners, launched a funding opportunity for 10 clinical research professionals to test therapies to mitigate the rapid spread of COVID-19.
“This virus is one of the most serious public health emergencies the world has faced in many years,” said Roussin. “This fund will ensure important research can take place to help fight this virus and develop new ways to identify and treat patients, as well as develop strong partnerships to move this work forward.”
“We are proud to partner with Research Manitoba on this important work,” said Economic Development and Training Minister Ralph Eichler. “Agile and innovative thinking is what we need in rapidly evolving times such as these, and investments into research and development will help advance our understanding and ability to treat COVID-19.”
Local clinical and scientific researchers and senior officials from the Manitoba government, Shared Health and the Winnipeg Regional Health Authority (WRHA) have identified several new research projects. These include projects to test possible treatments in clinical trials, better understand how the disease is developing in Manitoba and better understand how the health system needs to react to different complications that are emerging around the world.
“We are pleased to refocus our research efforts on vital clinical trials and potential interventions in the fight against COVID-19,” said Tracey Maconachie, chair, Research Manitoba. “Our world-renowned partners are conducting leading-edge research that could expedite treatments for Manitobans and all Canadians.”
More than $3.5 million will be used to support clinical and applied research including $700,000 for Manitoba’s first COVID-19 clinical trial for a drug to fight this virus, the minister said. The study will test whether or not the drug hydroxychloroquine, used to treat rheumatology issues, can prevent people from contracting COVID-19. The scientific trial will determine if the drug can safely be used as a treatment for COVID-19.
“We are building on the work of preliminary studies to look at how this drug could help fight the spread of COVID-19,” said Dr. Ryan Zarychanski, associate professor, department of internal medicine, Max Rady College of Medicine, University of Manitoba and department of medical oncology and hematology, CancerCare Manitoba. “We are asking Manitobans who meet the study’s criteria to consider joining this trial to help us scientifically prove the benefits for Manitobans and people around the world.”
An additional $500,000 will be invested in partnerships with industry and philanthropic sources supporting existing trials based in Manitoba but with sites across Canada and in seven other countries around the world, Friesen said, adding $1 million will be invested in COVID-19 innovation projects including looking at the development of diagnostic tools.
“While we have learned a great deal about this virus in just a few months, there are many more questions that need to be answered,” said Friesen. “These investments will help contribute to the world’s understanding of the virus and make important strides toward vaccines, treatments and possible changes to our health system to better combat COVID-19.”
Manitobans who wish to participate in the clinical trial can visit www.covid-19research.ca for additional details.
For more information on COVID-19, visit www.manitoba.ca/covid19.
A comprehensive list of Manitoba government COVID-19 measures can be found at https://manitoba.ca/bg/2020/04/covid19.html
Research Manitoba Funds Manitoba-led COVID-19 Research Projects
March 20, 2020 – Winnipeg, Manitoba
Today Research Manitoba announced that they are partnering with the Canadian Institutes of Health Research (CIHR) to invest $800,000 to support three research projects through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity. The researchers are:
- Adolf Ng - An Investigation on Epidemic Logistical Response and Planning: The Case of Novel Coronavirus (Covid-19) - $258,900 – fully funded by Research Manitoba
- Bradley Pickering, Development of field-deployable and point-of-need diagnostics for SARS-CoV-2 using CRISPR-based technology - $411,820 ($270,550 Research Manitoba and $140,270 CIHR)
- Xiao-Jian Yao, Development of a novel DC-targeting vaccine that targets COVID-19 spike protein to control COVID-19 infection - $597,128 ($270,550 Research Manitoba and $326,578 CIHR)
These are 3 of 16 projects supported by CIHR in Manitoba and of 96 projects across Canada that will focus on developing and implementing measures to rapidly detect, manage, and reduce the transmission of COVID-19.
“Investing in COVID-19 research is a global priority,” said Christina Weise, CEO of Research Manitoba. “We are pleased to support these three local teams, which are part of a worldwide scientific effort in response to the COVID-19 pandemic.”
2020 Research Manitoba/Rady Faculty of Health Sciences Graduate Entrance Scholarship
March 20, 2020
Research Manitoba and the University of Manitoba Rady Faculty of Health Sciences are pleased to announce the recipients of the 2020 Research Manitoba/Rady Faculty of Health Sciences Graduate Entrance Scholarship!
All applicants are welcome to log into their GMS account to check the status of their application. Comments from reviewers will be posted for early April.
If you require any technical support with the GMS please email firstname.lastname@example.org.
If you have any questions regarding your award please contact Dr. Hope Anderson, Vice-Dean Graduate Studies, Rady Faculty of Health Sciences at: email@example.com.
COVID-19 Update #1
Research Manitoba is actively monitoring the emerging and rapidly evolving COVID-19 situation. We are taking proactive measures to ensure that we maintain a safe environment for our staff, review committees, and stakeholders.
Visitors to Research Manitoba:
The organization is transitioning face-to-face meetings to virtual or teleconference formats until further notice. The new approach is a safeguard as Research Manitoba's ongoing business is important and meetings should continue.
Office Hours and Availability:
As of March 15, 2020 we are enabling employees to work from home to help slow the spread of the virus. Our employees will continue to be available during office hours Monday to Friday via their email and office phone numbers.
We will revisit this decision in early April. Should anything change, updates will be provided.
News and Information:
Our updates and news will be available at https://researchmanitoba.ca/about/news-releases/. You can also follow us on Twitter - @Research_MB.
Questions or Concerns:
If you have questions or concerns about our programs or funding please email us at firstname.lastname@example.org or visit the website. Our help desk hours are from 8:30 am to 4:30 pm Monday to Friday. We may take up to 24 hours to respond at this time.
We sincerely appreciate your patience and flexibility.
From all of us at Research Manitoba
COVID-19 - Travel Cancellations
March 12, 2020
Given the rapidly changing situation involving COVID-19, Research Manitoba recognizes that there may be an impact on researchers with plans to travel for meetings or other research-related activities.
Individuals may decide to cancel trips as a result of various considerations and factors such as cancelled conferences, travel advisories (including those from Health Canada and Global Affairs Canada), or personal choice due to health or other concerns.
Research Manitoba confirms that the reimbursement of non-refundable travel fees from our research funds is acceptable considering the impacts of COVID-19. This applies to the travel of both principal investigators and research personnel, when cancellation occurs as described above.
If you have any questions regarding this please contact email@example.com.
Mitacs Internships Create Emerging Opportunities for Industry in Manitoba
March 10, 2020, Winnipeg, MB – Today, Research Manitoba and Mitacs announced the release of an Impact Report titled: Research Partnerships in Manitoba Leverage Innovation.
Research Manitoba collaborated with Mitacs to develop this report to describe the results and impacts of Manitoba-based research and communicate the impacts to a wide variety of audiences. Some of the key results published in the report include:
-Research Manitoba invested $850,000, which supported 221 internships — leveraging $5.7 million from industry and national partners in 2018–19 for research in Manitoba
-Investing in interns creates jobs in Manitoba
-The students developing unique skills and expertise enhance and strengthen Manitoba’s workforce
-Economic growth in Manitoba is created through the expansion of and innovations developed by Mitacs partner companies
$1 Million Investment in Prairie Research Kitchen
November 7, 2019
Investment in Red River College's Culinary Research Laboratory Supports Province's Dynamic Food Industry
The Manitoba government is investing $1 million through Research Manitoba in innovative culinary research at Red River College (RRC), Economic Development and Training Minister Ralph Eichler announced today.
“This investment helps further cutting-edge research in Manitoba’s agriculture and food industry, and bring new ideas and products to life,” said Eichler at the grand opening of RRC’s Prairie Research Kitchen. “Culinary research is an area of tremendous opportunity. The Prairie Research Kitchen provides a pathway to developing agri-food products that are not only good for our health, but are good for the Manitoba economy.”
The Prairie Research Kitchen at RRC’s Paterson GlobalFoods Institute will provide a dedicated workspace for culinary research and innovation that will serve Western Canada’s food production industry. The facility brings together food scientists, culinary arts and small-to-medium sized businesses to develop new products and teach culinary students food science skills.
Investing in Manitoba's Future
September 25, 2019
$1.24M Investment in research will support Master’s Students and Early Career Researchers
Research Manitoba announced today $1,293,295 in research funding to support 25 Master’s students and 12 early career researchers in Manitoba.
“By investing in these individuals, we are advancing our province’s world class research enterprise, growing Manitoba’s economy, and developing talent for today and tomorrow,” said Christina Weise, Chief Executive Officer at Research Manitoba. “Research is a driver of Manitoba’s prosperity and we would like to thank our partners who have been with us on this journey for the last several years.”
CancerCare Manitoba Foundation, Children’s Hospital Research Institute of Manitoba (CHRIM), Health Sciences Centre Foundation, and the Lung Association, Manitoba are providing an additional $100,950 in support of the 2019 Master’s Studentships.
Research Manitoba CEO, Ms Christina Weise, announcing $1.24 M in research funding for Master's students and early career researchers.
2018 John R. Evans Leaders Fund Awards
March 14, 2019
Funding our Future through Research Excellence
Research Manitoba announced today $1,151,730 in research funding for seven University of Manitoba projects supported through the John R. Evans Leaders Fund (JELF) of the Canada Foundation for Innovation (CFI). The Honourable Kirsty Duncan, Minister of Science and Sport, was in Winnipeg to announce matching federal funds and to celebrate the achievements of the Manitoba awardees.
Announcement - 2018 Trainee Awards
Research Competition Update:
Results for the 2018 Trainee Award Competition are now available.
Applicants can login to their GMS accounts to learn their score and whether they have been offered funding.
2018 GRANTS & AWARDS COMPETITION
May 3, 2018
The 2018 Grants and Awards Competition is now open.
MASTER’S TRAINEE PROGRAM:
• Application Deadline is FRIDAY, JUNE 8, 2018 (4:00PM CST)
• Referee letter deadline is Friday, June 22, 2018 (4:00PM CST)
There will be up to 11 awards will be awarded in each category (health, social sciences and the humanities, natural sciences and engineering)
• Awarded on a competitive basis and are valued at $12,000 annually
• Will begin on September 1st, 2018 for a 1-year period
• For more info please visit our webpage - Master's Studentships
NEW INVESTIGATOR PROGRAM:
• Application Deadline is TUESDAY, JULY 31, 2018 (4:00PM CST)
• Referee letter deadline is Tuesday, August 14, 2018 (4:00PM CST)
• $65,000 per year in the Health category
• $25,000 per year in the Natural Sciences and Engineering category
• $20,000 per year in the Social Sciences and Humanities category
• The amount of funds that may be used for equipment is limited to $10,000 (for small equipment), over the two years of the grant
• For more information please visit our webpage - New Investigator Operating Grants
Research Manitoba Announces Programs for 2018/19
April 30, 2018
We would like to thank the research community for being patient over the last year as Research Manitoba underwent a strategic planning process. The intent of the process was to provide our organization with a road map and establish a spectrum of funding programs that would bring the most impact to the Provincial research enterprise.
Research Manitoba’s strategic plan for 2018/19 to 2020/21 is the result of extensive engagement with our internal and external stakeholders and identifies areas of emphasis and critical issues that need to be addressed over the next three years. The plan sets out our high-level strategic goals for the next three years, which are: support the generation of research, impact policy and practice through knowledge translation, and strengthen capacity for research in Manitoba.
Research Manitoba - Budget
A Message from Ms. Christina Weise, Chief Executive Officer, Research Manitoba
March 14, 2018
Research Manitoba has a new annual budget of $12 million, which is a $3 million reduction from the 2017/18 fiscal year. We will continue to promote and support, and coordinate the funding of, research in the health, natural and social sciences, engineering and the humanities in Manitoba.
The Board of Directors and staff are in the final stages of an extensive strategic review of our activities. These efforts will help us to forge a new set of programs and organizational direction, which will be announced shortly.
We are committed to keeping our stakeholders and members of the research community informed throughout this process.
Please send all inquiries or questions to firstname.lastname@example.org.
Follow @ResearchMB on twitter for news and updates.
Click HERE for a PDF of the message.
SPOR - Networks in Chronic Disease
SPOR Network - Innovation in Pediatric Clinical Trials (IPCT) Project
PRESCRIBING THE RIGHT MEDICINE FOR CHILDREN
8.4 million in new research funding for national partnerships
June 16, 2017
Today, the University of Manitoba announced more than $8.4 million in new research funding provided by the Canadian Institutes of Health Research (CIHR), Research Manitoba, and the Children’s Hospital Foundation of Manitoba in partnership with other institutions across Canada.
Led by Dr. Terry Klassen in the Rady Faculty of Health Sciences at the University of Manitoba, the SPOR Network - Innovation in Pediatric Clinical Trials (IPCT) Project will use real patients under carefully controlled situations to measure how well a medication works and how safe it is. Knowledge gained from trials will help doctors choose which medicines to prescribe.
Click here to download the full release.
Photo from left to right:
Dr. Jay Doering, Associate Vice-President (Partnerships), University of Manitoba
Mr. Terry Duguid, Member of Parliament for Winnipeg South, and Parliamentary Secretary to the Minister of Status of Women
Dr. Terry Klassen, CEO and Scientific Director Children’s Hospital Research Institute of Manitoba; Professor and Head, Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba; Medical Director, Child Health Program, WRHA; and Academic Director, CHI
Dr. Brian Postl, Dean, Rady Faculty of Health Sciences & Vice-Provost (Health Sciences), University of Manitoba, and Chair, Research Manitoba
The Honourable Cliff Cullen, Minister of Growth, Enterprise and Trade, Province of Manitoba
Mr. Lawrence Prout, President and CEO, Children's Hospital Foundation of Manitoba Inc.
Research Manitoba - New Budget
April 13, 2017
A Message from Dr. Brian Postl, Chair of Research Manitoba Board of Directors:
Research Manitoba has a new annual budget of $15 million, which is a $2 million reduction from previous years. We will continue to promote and support, and coordinate the funding of, research in the health, natural and social sciences, engineering and the humanities in Manitoba.
The Board of Directors and staff are reviewing our budget and expected expenditures in the short term and will be undertaking a longer term strategic review of our activities. We are committed to keeping our stakeholders and members of the research community informed throughout this process.
Please send all inquiries or questions to email@example.com.
Follow @ResearchMB on twitter for news and updates.
MANITOBA AND GENOME CANADA INVEST IN RESEARCH IN CANADA’S ARCTIC - GENICE Project
$4 Million Investment for Genomics Research in Oil Spill Preparedness and Emergency Response in Arctic Marine Environment
Research Manitoba and The Government of Canada today announced $4 million in funding for GENICE: a large-scale applied research project (LSARP). LSARP is one of Genome Canada’s funding programs and is aimed at projects using genomic approaches to address challenges and opportunities of importance to Canada’s natural resources, including interactions between natural resources and the environment, thereby contributing to Canada’s bioeconomy and the well-being of Canadians.
(Photo from left to right)
Dr. Digvir Jayas, Vice-President (Research and International) and Distinguished Professor, University of Manitoba
Ms. Christina Weise, Chief Executive Officer, Research Manitoba
Dr. Simon Potter, Director of Operations, Genome Prairie
Dr. Gary Stern, Research Professor, Centre for Earth Observation Science (CEOS), University of Manitoba
Dr. Casey Hubert, Associate Professor, Department of Biological Sciences, University of Calgary
Ms. Sarah Guillemard, MLA for Fort Richmond
Terry Duguid, Parliamentary Secretary to the Minister of Families, Children and Social Development; Member of Parliament for Winnipeg South
$1.4M in Funding for MITACS
Research Manitoba and Mitacs announce funding to support innovation,
job creation, and skills development
December 2, 2015 - Today, Research Manitoba announced $1.4 million of funding to support research internships between researchers and local companies or not-for-profits.
Mitacs connects companies and not-for-profit organizations with local experts in the academic community to address their research and development challenges. These collaborations promote innovation in Manitoba.
Manitoba Dementia Research Chair
PROVINCE ANNOUNCES MORE MONEY FOR DEMENTIA RESEARCH IN MANITOBA
August 18, 2015 - More investments for research into dementia are being made through Research Manitoba and in partnership with the Alzheimer Society of Manitoba, Jobs and Economy Minister Kevin Chief announced today.
“With an aging population, there has never been a more important time to profile dementia research,” said Minister Chief. “We understand the contribution our seniors have made to this province and today’s announcement will put more resources in place so that we can better understand the best ways to treat and diagnose dementia.”
Today’s announcement recognizes Dr. Benedict Albensi as the recipient of the Manitoba Dementia Research Chair. Albensi is a professor in the department of pharmacology and therapeutics, faculty of health sciences, college of medicine, University of Manitoba and principal investigator, synaptic plasticity and cellular memory dysfunction in the neurodegenerative disorders division of St-Boniface Hospital Research Centre.
2014 Applied Health Services Research Recipients
January 6, 2015 - Research Manitoba is pleased to announce the 2014 Applied Health Services Research Grants. The funds that support Research Manitoba’s Applied Health Services Grants are provided through the Winnipeg Regional Health Authority.
Research Manitoba partnered with Manitoba Health, the regional health authorities, and the George and Fay Yee Centre for Healthcare Innovation (CHI) to support applied health services research. This focus area is important to the health system in Manitoba and supports collaborations between policy makers, service providers, and researchers interested in working together to address health system challenges.
Province Establishes Research Manitoba
The Manitoba government is establishing Research Manitoba, a new research funding organization that will bring existing research funding sources into a single, co-ordinated organization, under the chairmanship of Dr. Brian Postl, Jobs and the Economy Minister Theresa Oswald announced today.
National MS Clinical Trial Receives Approval, Patients Recruitment to Start by November 1
Halifax, September 28, 2012
The Honourable Leona Aglukkaq, Minister of Health, today announced that a national MS clinical trial has received the necessary medical and ethical approvals required to proceed. The clinical trial is a collaborative initiative between the Government of Canada, the provinces and territories and the MS Society of Canada.
MHRC PROVIDES UPDATE ON MS CLINICAL TRIALS
September 27, 2012
The Manitoba Health Research Council (MHRC) today provided an update on the national call for proposals for clinical trials for studying the treatments for CCSVI in Multiple Sclerosis (MS).